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Introduction to Liver transplantation fibrinolysis
• Fibrinolysis is a recognized problem during liver transplant 
surgeries, especially during the reperfusion phase1
• Modern liver transplantations use significantly less amounts 
of blood products compared to historical liver 
transplantations 2
• The rate of fibrinolysis may have changed alongside improving 
surgical techniques, thus patients may be receiving 
unnecessary blood products
• Liver transplant surgical techniques may become more 
efficient, safer, and less costly if fibrinolysis is not happening 
as frequently as what is currently believed
Research Question
Research question: Using a Rotational thromboelastometry (ROTEM) 
machine to measure clotting, is the rate of fibrinolysis during modern liver 
transplant surgery as high as what is currently believed (~15%)?
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Hypothesis: The patients who underwent liver 
transplantation surgeries at Jefferson from 
2013-2019 have a significantly lower (<5%) rate 
of hyperfibrinolysis, as measured by ROTEM 
clotting parameters, compared to what has been 
described in previous literature (~15%).
Methods
• Retrospective chart review using ROTEM data from 312 liver 
transplant surgeries that took place at Jefferson from 2013-2019
– ROTEM (Rotational thrombelastography): a machine capable 
of intraoperatively assessing several qualities of a clot from a 
whole blood assay
• Rate of fibrinolysis, clot formation time, clot strength etc.
• Data collection: The data was taken from the ROTEM machines 
and has been matched with patient information from EPIC
• Analysis: Blood was collected at several distinct time points 
during the surgery and the clotting profile was assessed
• Outcome of interest: Is hyperfibrinolysis* present at any point 
during the surgery?
*Hyperfibrinolysis is defined a Maximum Lysis Value greater than 15% on NATEM
And a correction of hyperfibrinolysis on APTEM
Methods continued
• An example of the type of data that ROTEM provides 3
• Note, this information is available during surgery
Results
• Population:
– Average age at transplantation was 58±11.2 years 
– About 67% of the recipients were men
– Alcohol (24%), Hepatitis C (22%), and HCC (21%) were the most common 
reasons for transplantation
• Hyperfibrinolysis:
– There were 20 patients out of 321 (6.1%) who had hyperfibrinolysis
– Factors not found to be related to hyperfibrinolysis
• MELD score 
• INR 
• Intraoperative clot strength 
– Factors found to be related to hyperfibrinolysis
• Non-alcohol reason for transplantation 
• Multiple causative factors of liver injury 
• Age 
• Third stage of surgery
Conclusions
• Overall, the study appears to show that 
hyperfibrinolysis occurs less often than what is 
currently believed
• Potential predicative factors such as age, and 
reason for transplantation have been identified
• Hyperfibrinolysis remains a serious concern 
during liver transplantation surgeries and still 
needs to be rigorously monitored
Future Directions
• Search the data base for additional clotting parameters that 
can be used to predict coagulopathies
• Gather additional demographic and anesthesia information 
from the surgeries
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